Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

The aftermath of the Merck's HIV vaccine trial

Enrico Iaccino* email, Marco Schiavone* email, Giuseppe Fiume* email, Ileana Quinto email and Giuseppe Scala email

Retrovirology 2008, 5:56doi:10.1186/1742-4690-5-56

No comments have yet been made on this article

Post a comment


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.